drugset / Trial / NCT00386360
Study of the Effect of Once a Week Risedronate on the Microstructure of Tibia and Radius Using a New Scanning Method
RandomizedParallel-groupQuadruple-blindPrevention
Summary
The primary purpose of the protocol is to evaluate the sensitivity of 3D-pQCT (3D-Peripheral Quantitative Computed Tomography) technology to detect minute changes in bone microarchitecture.
Timeline
- Start
- 2006-04
- Primary completion
- 2009-09
- Completion
- 2009-09
Outcome
Missed primary endpoint
registry analysis (superiority or other test); Placebo vs Risedronate; p = 0.7096; LS Mean Difference 0.231 (95% CI -0.995 to 1.458); ANOVA NCT00386360 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Risedronate | Small molecule | 35 mg | — |